Cao HC, Chen XM, Xu W. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis.
World J Gastroenterol 2005;
11:7364-7367. [PMID:
16437644 PMCID:
PMC4725131 DOI:
10.3748/wjg.v11.i46.7364]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2005] [Revised: 07/21/2005] [Accepted: 07/21/2005] [Indexed: 02/06/2023] Open
Abstract
AIM
To detect the platelet-activating factor (PAF) and the plasma or serum levels of tumor necrosis factor-alpha (TNF-alpha) malondialdehyde (MDA), endotoxin (ET) and to discuss their significance in various types of viral hepatitis.
METHODS
PAF, TNF-alpha, MDA, and ET levels in 60 controls, 16 cases of acute viral hepatitis, 71 cases of chronic viral hepatitis, 19 cases of severe viral hepatitis were detected by reverse phase high-performance liquid chromatography (rHPLC), bio-assay, ELISA, thiobarbituric acid (TBA), and limulus lysate test (LLT), respectively.
RESULTS
The rHPLC was more sensitive and specific than bio-assay (r = 0.912, P<0.01). The plasma levels of PAF, TNF-alpha, MDA, and ET in patients with viral hepatitis were higher than those in controls (P<0.01).
CONCLUSION
rHPLC is more reliable and accurate for the detection of PAF.
Collapse